ConductScience.org, home

Trial · NCT07900230

The GEIR (Grupo español de Ictus Retina) Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain

NCT07900230, Not yet recruiting, Germans Trias i Pujol Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The GEIR (Grupo español de Ictus Retina) Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain. Trials, record NCT07900230. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900230

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The GEIR (Grupo español de Ictus Retina) Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain
NCT number
NCT07900230
Status
Not yet recruiting
Enrollment
500 participants, estimated
Lead sponsor
Germans Trias i Pujol Hospital
Conditions
Retinal Artery Occlusion, Central Retinal Artery Occlusion, Retinal Ischemia, Cilioretinal Arteries
First posted
2026-10-28
Last updated
2026-11-06

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarynational research registry platform2026.12 - 2030.12To establish the first nationwide retinal stroke registry in Spain.
PrimaryTo estimate the epidemiological burden of retinal stroke.2026.12 - 2030.12To estimate the national epidemiological burden of retinal stroke in Spain.
PrimaryTo characterise healthcare pathways and access to reperfusion therapies.2026.12 - 2030.12To characterise national healthcare pathways and access to reperfusion therapies in Spain
PrimaryTo describe the natural history of retinal stroke.2026.12 - 2030.12Retinal stroke natural history in Spain
PrimaryTo identify clinical, neurovascular and imaging predictors of visual recovery.2026.12 - 2030.12searching imaging predictors of visual recovery
PrimaryTo investigate OCT biomarkers associated with retinal viability and treatment response. [CEIC GEIR HUGTiP | Word] and precise the time of retinal ischemia2026.12 - 2030.12searching OCT biomarkers of retinal viability

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
38189284RESULTPubMed
38670259BACKGROUNDPubMed
39147633BACKGROUNDPubMed
41818386BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07900230

GET https://conductscience.org/api/trials/v1/NCT07900230/registered